A polypeptide model for toxic aberrant proteins induced by aminoglycoside antibiotics

PLoS One. 2022 Apr 29;17(4):e0258794. doi: 10.1371/journal.pone.0258794. eCollection 2022.

Abstract

Aminoglycoside antibiotics interfere with the selection of cognate tRNAs during translation, resulting in the synthesis of aberrant proteins that are the ultimate cause of cell death. However, the toxic potential of aberrant proteins and how they avoid degradation by the cell's protein quality control (QC) machinery are not understood. Here we report that levels of the heat shock (HS) transcription factor σ32 increased sharply following exposure of Escherichia coli to the aminoglycoside kanamycin (Kan), suggesting that at least some of the aberrant proteins synthesized in these cells were recognized as substrates by DnaK, a molecular chaperone that regulates the HS response, the major protein QC pathway in bacteria. To further investigate aberrant protein toxic potential and interaction with cell QC factors, we studied an acutely toxic 48-residue polypeptide (ARF48) that is encoded by an alternate reading frame in a plant cDNA. As occurred in cells exposed to Kan, σ32 levels were strongly elevated following ARF48 expression, suggesting that ARF48 was recognized as a substrate by DnaK. Paradoxically, an internal 10-residue region that was tightly bound by DnaK in vitro also was required for the ARF48 toxic effect. Despite the increased levels of σ32, levels of several HS proteins were unchanged following ARF48 expression, suggesting that the HS response had been aborted. Nucleoids were condensed and cell permeability increased rapidly following ARF48 expression, together suggesting that ARF48 disrupts DNA-membrane interactions that could be required for efficient gene expression. Our results are consistent with earlier studies showing that aberrant proteins induced by aminoglycoside antibiotics disrupt cell membrane integrity. Insights into the mechanism for this effect could be gained by further study of the ARF48 model system.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aminoglycosides / metabolism
  • Aminoglycosides / toxicity
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / toxicity
  • Escherichia coli / metabolism
  • Escherichia coli Proteins* / metabolism
  • HSP70 Heat-Shock Proteins / genetics
  • HSP70 Heat-Shock Proteins / metabolism
  • Peptides / metabolism
  • Sigma Factor* / genetics
  • Transcription Factors / metabolism

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • HSP70 Heat-Shock Proteins
  • Peptides
  • Sigma Factor
  • Transcription Factors

Grants and funding

This work was supported by a Brookhaven National Laboratory-directed Research and Development award (LDRD 10-051) to P.F. and in part by the U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Visiting Faculty Program (VFP). M.T. also was supported by NSF STEP 0652963, and A.B. by NSF-LSAMP at Cheyney University under the LSAMP internship program at Brookhaven National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.